Board of Directors


Boyd W. Hendrickson

LEAD DIRECTOR - LTC BOARD MEMBER SINCE 2005

Member Audit, Compensation, Nominating and Corporate Governance Committees
 
Boyd Hendrickson served as the Chief Executive Officer of Skilled Healthcare Group, Inc. (SHG) for 11 years starting in April 2002, and also served on its Board from August 2003 through November 2013. He was Chairman of the SHG Board from December 2005 through November 2013, and served as a consultant to the company from November 2013 through December 2014. SHG, an owner and operator of skilled nursing and assisted living facilities, was acquired by Genesis HealthCare, Inc. (NYSE: GEN) in February 2015. Prior to joining SHG, Mr. Hendrickson was the President and Chief Executive Officer of Evergreen Healthcare, LLC, an operator of long-term health care facilities. Additionally, he has served as a managing member of Executive Search Solutions, LLC, a provider of recruiting services to the health care services industry, since 2005. Mr. Hendrickson is a member of the Board of Directors of Earthling Interactive, a private software development company, and is a former member of the senior management teams and Boards of Beverly Enterprises, Inc. and Hallmark Health Services. Mr. Hendrickson was nominated to serve as an LTC director for the current term due to his prior service as an independent director of LTC, past executive and director experience with other public companies, and his multi-decade involvement in the health care industry.

James J. Pieczynski

LTC BOARD MEMBER SINCE 2014

Member Audit (financial expert), Compensation, and Nominating and Corporate Governance (Chairman) Committees
 
James Pieczynski is currently President of the CapitalSource division of Pacific Western Bank, and a member of the Boards of Directors of Pacific Western Bank and PacWest Bancorp. He was a member of the Board of Directors of CapitalSource, Inc. (CSE) from January 2010 until April 2014 when CSE was acquired by PacWest Bancorp. Mr. Pieczynski served as Chief Executive Officer of CSE from January 2012 until the acquisition, as CSE’s Co-Chief Executive Officer from January 2010 through December 2011, its President—Healthcare Real Estate Business from November 2008 until January 2010, and its Co-President—Healthcare and Specialty Finance from January 2006 until November 2008. CSE was a publicly held bank providing commercial loans to small and middle-market businesses nationwide, and depository products and services in southern and central California. Mr. Pieczynski was an executive officer of LTC from 1994 to 2001, and was a member of the company’s Board of Directors from 1997 to 2001. Mr. Pieczynski was nominated to serve as an LTC director for the current term due to his prior service as an executive officer and director of LTC, his recent position as Chief Executive Officer of a public financial company, his years of experience in financial and executive positions with health care companies, and his expertise in accounting, financial reporting and controls. 

Devra G. Shapiro

LTC BOARD MEMBER SINCE 2009

Member Audit (Chairman and Financial Expert), Compensation, and Nominating and Corporate Governance Committees
 
Devra Shapiro served as Chief Financial Officer of IPC Healthcare, Inc. (IPC) from the time she joined IPC in March 1998 through October 2011. From 2011 to her retirement in 2014, she served as IPC's Chief Administrative Officer. IPC was a publicly traded national physician group practice company focused on the delivery of acute and post-acute hospitalist medicine services which was acquired by Team Health in 2015. Prior to joining IPC, Ms. Shapiro held Chief Financial Officer and other executive financial positions with several health care companies, and served in the health care practice of an international accounting firm for 11 years. Formerly, she was with Arthur Andersen & Company. Ms. Shapiro was nominated to serve as an LTC director for the current term due to her prior service as a director of LTC, her 16 years experience as a senior executive of a public health care company, her many years of experience in financial and executive positions with health care companies and in public accounting, and her expertise in accounting, financial reporting and controls.

Wendy L. Simpson

LTC BOARD MEMBER SINCE 1995

Chairman, President and Chief Executive Officer
 
Wendy Simpson has been LTC’s CEO and President since 2007, and its Chairman of the Board since 2013. Since joining the company in 2000 as Vice Chairman, Ms. Simpson has served as LTC’s Treasurer, Chief Financial Officer and Chief Operating Officer. With more than 25 years of experience at health care-related businesses, Ms. Simpson has held executive positions of increasing responsibility at publicly traded companies that own acute care hospitals, long-term acute care hospitals, psychiatric hospitals and home health services. She began her career in public accounting.  Ms. Simpson has served on the boards of CLC Healthcare Inc., an operator of nursing facilities, since 2001 and Community Psychiatric Centers, a provider of behavioral health services, since 1996. Ms. Simpson was nominated to serve as an LTC director for the current term due to her prior service as an executive and director of LTC, her deep understanding of the company's historical and current business and financial operations, and because LTC’s Corporate Governance Guidelines require that the company’s CEO be nominated to serve on its Board.

Timothy J. Triche, MD

LTC BOARD MEMBER SINCE 2000

Member Audit, Compensation (Chairman), and Nominating and Corporate Governance Committees
 

Dr. Timothy Triche has been the Director of the Center for Personalized Medicine at Children’s Hospital Los Angeles since July 2010, and previously served as the Chairman of the Department of Pathology and Laboratory Medicine there since 1988. He has also been a Professor of Pathology and Pediatrics at the USC Keck School of Medicine since 1988. He serves on the Board of Directors of several biotechnology and related companies including Novelix Pharmaceuticals, Inc., NanoValent Pharmaceuticals, Inc., GenomeDx, Lifecode, Inc. (f/k/a Silicon Valley Biosystems), and Sanguine BioSciences. Dr. Triche was nominated to serve as an LTC director for the current term due to his prior service as an independent director of LTC, current and past executive and director experience with other health care companies, and his extensive background in the health care industry.